These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 11882576

  • 1. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
    Liu YH, Xu J, Yang XP, Yang F, Shesely E, Carretero OA.
    Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
    [Abstract] [Full Text] [Related]

  • 2. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice.
    Yang XP, Liu YH, Mehta D, Cavasin MA, Shesely E, Xu J, Liu F, Carretero OA.
    Circ Res; 2001 May 25; 88(10):1072-9. PubMed ID: 11375278
    [Abstract] [Full Text] [Related]

  • 3. Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury.
    Yang XP, Liu YH, Shesely EG, Bulagannawar M, Liu F, Carretero OA.
    Hypertension; 1999 Jul 25; 34(1):24-30. PubMed ID: 10406819
    [Abstract] [Full Text] [Related]

  • 4. Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice.
    Xu J, Carretero OA, Liu YH, Shesely EG, Yang F, Kapke A, Yang XP.
    Hypertension; 2002 Sep 25; 40(3):244-50. PubMed ID: 12215461
    [Abstract] [Full Text] [Related]

  • 5. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA.
    J Clin Invest; 1997 Apr 15; 99(8):1926-35. PubMed ID: 9109437
    [Abstract] [Full Text] [Related]

  • 6. Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure.
    Cavasin MA, Yang XP, Liu YH, Mehta D, Karumanchi R, Bulagannawar M, Carretero OA.
    J Cardiovasc Pharmacol; 2000 Oct 15; 36(4):472-80. PubMed ID: 11026648
    [Abstract] [Full Text] [Related]

  • 7. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
    Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, Heineke A, Spiekermann S, Hilfiker-Kleiner D, Templin C, Kotlarz D, Mueller M, Fuchs M, Hornig B, Haller H, Drexler H.
    Circulation; 2004 Oct 05; 110(14):1933-9. PubMed ID: 15466656
    [Abstract] [Full Text] [Related]

  • 8. The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice.
    Xu J, Carretero OA, Shesely EG, Rhaleb NE, Yang JJ, Bader M, Yang XP.
    Exp Physiol; 2009 Mar 05; 94(3):322-9. PubMed ID: 19060116
    [Abstract] [Full Text] [Related]

  • 9. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.
    Scherrer-Crosbie M, Ullrich R, Bloch KD, Nakajima H, Nasseri B, Aretz HT, Lindsey ML, Vançon AC, Huang PL, Lee RT, Zapol WM, Picard MH.
    Circulation; 2001 Sep 11; 104(11):1286-91. PubMed ID: 11551881
    [Abstract] [Full Text] [Related]

  • 10. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse.
    Patten RD, Aronovitz MJ, Einstein M, Lambert M, Pandian NG, Mendelsohn ME, Konstam MA.
    Clin Sci (Lond); 2003 Feb 11; 104(2):109-18. PubMed ID: 12546633
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of p38 mitogen-activated protein kinase protects the heart against cardiac remodeling in mice with heart failure resulting from myocardial infarction.
    Liu YH, Wang D, Rhaleb NE, Yang XP, Xu J, Sankey SS, Rudolph AE, Carretero OA.
    J Card Fail; 2005 Feb 11; 11(1):74-81. PubMed ID: 15704068
    [Abstract] [Full Text] [Related]

  • 12. Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction.
    Liu YH, Carretero OA, Cingolani OH, Liao TD, Sun Y, Xu J, Li LY, Pagano PJ, Yang JJ, Yang XP.
    Am J Physiol Heart Circ Physiol; 2005 Dec 11; 289(6):H2616-23. PubMed ID: 16055518
    [Abstract] [Full Text] [Related]

  • 13. Role of a selective aldosterone blocker in mice with chronic heart failure.
    Wang D, Liu YH, Yang XP, Rhaleb NE, Xu J, Peterson E, Rudolph AE, Carretero OA.
    J Card Fail; 2004 Feb 11; 10(1):67-73. PubMed ID: 14966777
    [Abstract] [Full Text] [Related]

  • 14. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
    Shimazu T, Otani H, Yoshioka K, Fujita M, Okazaki T, Iwasaka T.
    Am J Physiol Heart Circ Physiol; 2011 Nov 11; 301(5):H2061-72. PubMed ID: 21890687
    [Abstract] [Full Text] [Related]

  • 15. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Shiomi T, Tsutsui H, Hayashidani S, Suematsu N, Ikeuchi M, Wen J, Ishibashi M, Kubota T, Egashira K, Takeshita A.
    Circulation; 2002 Dec 10; 106(24):3126-32. PubMed ID: 12473562
    [Abstract] [Full Text] [Related]

  • 16. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats.
    Liu YH, Yang XP, Mehta D, Bulagannawar M, Scicli GM, Carretero OA.
    Am J Physiol Heart Circ Physiol; 2000 Feb 10; 278(2):H507-14. PubMed ID: 10666082
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction.
    Kompa AR, Lu J, Weller TJ, Kelly DJ, Krum H, von Lueder TG, Wang BH.
    Int J Cardiol; 2018 May 01; 258():192-198. PubMed ID: 29544929
    [Abstract] [Full Text] [Related]

  • 18. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD.
    Circ Res; 2004 May 14; 94(9):1256-62. PubMed ID: 15044322
    [Abstract] [Full Text] [Related]

  • 19. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction.
    Sam F, Sawyer DB, Xie Z, Chang DL, Ngoy S, Brenner DA, Siwik DA, Singh K, Apstein CS, Colucci WS.
    Circ Res; 2001 Aug 17; 89(4):351-6. PubMed ID: 11509452
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M, Nakamura Y, Omura T, Izumi Y, Matsumoto R, Oda S, Takeuchi K, Kim S, Iwao H, Yoshikawa J.
    Heart; 2005 Aug 17; 91(8):1080-5. PubMed ID: 16020603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.